Successful treatment with tirabrutinib for relapsed Bing-Neel syndrome following high-dose methotrexate and craniospinal irradiation.

MLA

Saburi, Masuho, et al. “Successful Treatment with Tirabrutinib for Relapsed Bing-Neel Syndrome Following High-Dose Methotrexate and Craniospinal Irradiation.” Journal of Clinical and Experimental Hematopathology : JCEH, vol. 62, no. 3, 2022, pp. 181–86. EBSCOhost, https://doi.org/10.3960/jslrt.22018.

APA

Saburi, M., Sakata, M., Okuhiro, K., Kawano, K., Uesugi, S., Wada, J., Urabe, S., Saburi, Y., & Ohtsuka, E. (2022). Successful treatment with tirabrutinib for relapsed Bing-Neel syndrome following high-dose methotrexate and craniospinal irradiation. Journal of Clinical and Experimental Hematopathology : JCEH, 62(3), 181–186. https://doi.org/10.3960/jslrt.22018

Chicago

Saburi, Masuho, Masanori Sakata, Kazuki Okuhiro, Katsuya Kawano, Souhei Uesugi, Junpei Wada, Shogo Urabe, Yoshio Saburi, and Eiichi Ohtsuka. 2022. “Successful Treatment with Tirabrutinib for Relapsed Bing-Neel Syndrome Following High-Dose Methotrexate and Craniospinal Irradiation.” Journal of Clinical and Experimental Hematopathology : JCEH 62 (3): 181–86. doi:10.3960/jslrt.22018.